BFPW
REGN icon

BOK Financial Private Wealth’s Regeneron Pharmaceuticals REGN Stock Holding History

BOK Financial Private Wealth’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.37K Buy
+7
New +$4.76K ﹤0.01% 515
2025
Q1 		– Sell
-5
Closed -$3.56K – 636
2024
Q4 		$3.56K Sell
5
-36
-88% -$30.2K ﹤0.01% 416
2024
Q3 		$43.1K Buy
41
+3
+8% +$3.34K ﹤0.01% 274
2024
Q2 		$39.9K Hold
38
– – ﹤0.01% 285
2024
Q1 		$36.6K Buy
+38
New +$36.1K ﹤0.01% 284
2022
Q2 		– Sell
-525
Closed -$367K – 438
2022
Q1 		$367K Buy
525
+182
+53% +$115K 0.03% 204
2021
Q4 		$217K Buy
+343
New +$211K 0.02% 283

Other funds holding REGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

BOK Financial Private Wealth's REGN Position: Q2 2026 in Review

BOK Financial Private Wealth opened a new position in Regeneron Pharmaceuticals (REGN) in Q2 2026: 7 shares worth $4.37K. The stake represents ﹤0.01% of the portfolio and ranks #515 among its holdings. This is a return to the name: BOK Financial Private Wealth previously reported a position in REGN as recently as Q4 2024.

BOK Financial Private Wealth first reported a position in REGN in Q4 2021 and has held it in 7 quarters since. The position peaked at $367K in Q1 2022. 1,336 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • BOK Financial Private Wealth held 7 shares of Regeneron Pharmaceuticals worth $4.37K as of Q2 2026.
  • Regeneron Pharmaceuticals was a new BOK Financial Private Wealth position in Q2 2026.
  • Regeneron Pharmaceuticals made up ﹤0.01% of BOK Financial Private Wealth's portfolio in Q2 2026, its #515 holding.
  • BOK Financial Private Wealth first reported a position in Regeneron Pharmaceuticals in Q4 2021 and has held it in 7 quarters since.
  • BOK Financial Private Wealth's Regeneron Pharmaceuticals position peaked at $367K in Q1 2022.
  • 1,336 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on BOK Financial Private Wealth's 13F filing for Q2 2026, filed 10 Aug 2026.